Robert Bowser, PhD is the Chief Scientific Officer, Professor and Chair of Translational Neuroscience at the Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. He obtained his PhD from Yale University, completed fellowship training at the Albert Einstein College of Medicine, and was faculty member at the University of Pittsburgh School of Medicine for 18 years prior to his recruitment by the Barrow Neurological Institute in 2011. Dr. Bowser’s research interests are to use biomarker discovery efforts to determine the molecular and cellular basis of neurodegeneration, and translate those findings back to the clinic. He leads efforts to incorporate biomarkers in both preclinical drug development and in clinical trials to monitor target engagement and drug efficacy. He has published over 200 peer-reviewed publications and holds a dozen patents around technologies developed in his laboratory. Dr. Bowser is co-Founder of two biotechnology companies, Knopp Biosciences, LLC and nVector, Inc (formally Iron Horse Diagnostics, Inc.), companies advancing new drug and gene therapy treatments and ways to diagnose neurologic disorders. He co-chairs the Northeast ALS (NEALS) biofluids biorepository and the Target ALS Biofluids & Postmortem Tissue Cores.